Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Current Opinion in Pulmonary Medicine
|
September 16, 2014
Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?
Lesley Uttley, Paul Tappenden
Pharmacoeconomics
|
July 17, 2014
Avoiding and identifying errors and other threats to the credibility of health economic models
Paul Tappenden, James B Chilcott
Pharmacoeconomics
|
October 24, 2019
Improving Transparency in Decision Models: Current Issues and Potential Solutions
Paul Tappenden, J Jaime Caro
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 17, 2013
Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments
Eva Kaltenthaler, Paul Tappenden, Suzy Paisley
Pharmacoeconomics
|
March 25, 2017
An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis
Paul Tappenden, Susannah Sadler, Martin Wildman
Pharmacoeconomics
|
July 28, 2017
Replicating Health Economic Models: Firm Foundations or a House of Cards?
Inigo Bermejo, Paul Tappenden, Ji-Hee Youn
Pharmacoeconomics
|
September 29, 2017
Response to 'Comment on "Replicating Health Economic Models: Firm Foundations or a House of Cards?"'
Inigo Bermejo, Paul Tappenden, Ji-Hee Youn
Pharmacoeconomics
|
May 19, 2021
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals
Tushar Srivastava, Nicholas R Latimer, Paul Tappenden
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 9, 2024
Assessing Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Simulation Study
Abualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
British Journal of Cancer
|
September 11, 2020
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer
Katy Cooper, Paul Tappenden, Anna Cantrell, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Current Opinion in Pulmonary Medicine
|
September 16, 2014
Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?
Lesley Uttley, Paul Tappenden
Pharmacoeconomics
|
July 17, 2014
Avoiding and identifying errors and other threats to the credibility of health economic models
Paul Tappenden, James B Chilcott
Pharmacoeconomics
|
October 24, 2019
Improving Transparency in Decision Models: Current Issues and Potential Solutions
Paul Tappenden, J Jaime Caro
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 17, 2013
Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments
Eva Kaltenthaler, Paul Tappenden, Suzy Paisley
Pharmacoeconomics
|
March 25, 2017
An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis
Paul Tappenden, Susannah Sadler, Martin Wildman
Pharmacoeconomics
|
July 28, 2017
Replicating Health Economic Models: Firm Foundations or a House of Cards?
Inigo Bermejo, Paul Tappenden, Ji-Hee Youn
Pharmacoeconomics
|
September 29, 2017
Response to 'Comment on "Replicating Health Economic Models: Firm Foundations or a House of Cards?"'
Inigo Bermejo, Paul Tappenden, Ji-Hee Youn
Pharmacoeconomics
|
May 19, 2021
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals
Tushar Srivastava, Nicholas R Latimer, Paul Tappenden
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 9, 2024
Assessing Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Simulation Study
Abualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
British Journal of Cancer
|
September 11, 2020
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer
Katy Cooper, Paul Tappenden, Anna Cantrell, et al.
Page
of 9